Comparison of different methods to estimate prevalence of drug use by using pharmacy records

Journal of Clinical Epidemiology

Volumn 54, Issue 11, 2001, Pages 1181-1186

  Mantel Teeuwisse, Aukje K ^a   Klungel, Olaf H ^a   Verschuren, W M Monique ^b   Porsius, Arijan ^a   De Boer, Anthonius ^a  

^a UTRECHT UNIVERSITY   (Netherlands)

^b NATIONAL INSTITUTE FOR PUBLIC HEALTH AND THE ENVIRONMENT   (Netherlands)

Author keywords

Antilipemic drugs; Drug utilization; Epidemiologic methods; Pharmacy records; Prevalence; Standardization

Indexed keywords

HYPOCHOLESTEROLEMIC AGENT;

ARTICLE; DATA BASE; DOSE CALCULATION; DRUG USE; DRUG UTILIZATION; HUMAN; INFORMATION PROCESSING; INTERMETHOD COMPARISON; NETHERLANDS; PRESCRIPTION; PREVALENCE; PRIORITY JOURNAL; STANDARDIZATION;

ADULT; AGED; DRUG UTILIZATION; FEMALE; HUMANS; MALE; MEDICAL RECORD LINKAGE; MIDDLE AGED; NETHERLANDS; PHARMACOEPIDEMIOLOGY; PHYSICIAN'S PRACTICE PATTERNS; PREVALENCE;

EID: 0034766979     PISSN: 08954356     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0895-4356(01)00396-1     Document Type: Article

References (39)

1. Improving prescribing patterns for the elderly through an online drug utilization review intervention: A system linking the physician, pharmacist, and computer
2. Use of cholesterol-lowering drugs United States, 1992
3. Estimate of disease prevalence using drug consumption data
4. Dispensing epilepsy medication: A method of determining the frequency of symptomatic individuals with seizures
5. The computerized on-line Medicaid pharmaceutical analysis and surveillance system: A new resource for postmarketing drug surveillance
6. External quality assessment of trans-European multicentre antigen determinations (enzyme-linked immunosorbent assay) of urokinase-type plasminogen activator (uPA) and its type 1 inhibitor (PAI-1) in human breast cancer tissue extracts
7. European interlaboratory comparison of breath 13CO2 analysis
8. Primers and protocols for standardized detection of minimal residual disease in acute lymphoblastic leukemia using immunoglobulin and T cell receptor gene rearrangements and TAL1 deletions as PCR targets: Report of the BIOMED-1 CONCERTED ACTION: Investigation of minimal residual disease in acute leukemia
9. A European version of the Appropriateness Evaluation Protocol. Goals and presentation
10. Prevention of coronary heart disease in clinical practice. Summary of recommendations of the Second Joint Task Force of European and other Societies on Coronary Prevention
11. Variations in case fatality and dependency from stroke in western and central Europe
12. Prescribing patterns of antilipemic drugs and prevalence of hypercholesterolemia in the Nova Scotia population more than 65 years old
13. Lack of adherence to lipid-lowering drug treatment. A comparison of utilization patterns in defined populations in Funen, Denmark and Bologna, Italy
14. Use of statins in general practices, 1996-8: Cross sectional study
15. Time trends in the use of cholesterol-lowering agents in older adults: The Cardiovascular Health Study
16. The prescribing of lipid lowering drugs during a 1-year period: Analysis of 7490 health insurance files
17. Growth in use of statins after trials is not targeted to most appropriate patients
18. Worldwide occurrence of Parkinson's disease: An updated review
19. Age standardisation of drug utilisation: Comparisons of different methods using cardiovascular drug data from Sweden and Spain
20. Comparing period prevalences with application to drug utilization
21. Measurement methods of drug consumption as a secondary judgment criterion for clinical trials in chronic rheumatic diseases
22. Validation of pharmacy records in drug exposure assessment
23. Comparing groups: Categorical data
24. Completeness of prescription recording in outpatient medical records from a health maintenance organization
25. Comparison of prescription and medical records in reflecting patient antihypertensive drug therapy
26. Recall accuracy for prescription medications: Self-report compared with database information
27. Trends in cholesterol knowledge and screening and hypercholesterolemia awareness and treatment, 1980-1992. The Minnesota Heart Survey
28. Use of prevalence and incidence measures to describe age-related prescribing of antidepressants with and without anticholinergic effects
29. Discontinuation of antihyperlipidemic drugs - Do rates reported in clinical trials reflect rates in primary care settings?
30. Apparent discontinuation rates in patients prescribed lipid-lowering drugs
31. Defined daily doses in relation to hypolipidaemic efficacy of lovastatin, pravastatin, and simvastatin
32. Efficacy of low-density-lipoprotein lowering with statins
33. Stepped care for hypertension: Are the assumptions valid?
34. Nonadherence in asthmatic patients: Is there a solution to the problem?
35. General practitioners' perceptions of the tolerability of antidepressant drugs: A comparison of selective serotonin reuptake inhibitors and tricyclic antidepressants
36. Compliance to drug treatment of patients with rheumatoid arthritis: A 3 year longitudinal study
37. Hormone replacement therapy among Danish women aged 45-65 years: Prevalence, determinants, and compliance